Plus: The U.S. and its allies are crafting a plan to fund Ukraine with interest payments from frozen Russian assets. Eli Lilly says it will spend more than $5 billion to boost production of weight-loss drug Zepbound and diabetes treatment Mounjaro. J.R. Whalen reports.
Sign up for the WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices